LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
Oct 19, 2022
Data Byte
The evolving geographic atrophy pipeline
Roche drops galegenimab and NGM data disappoint, as regulatory milestones approach for Apellis, Iveric
Read More
BioCentury
|
Jul 12, 2022
Finance
July 11 Quick Takes: Qiming announces $3.2B in new venture funds
Plus Innoviva buying La Jolla in diversification push and updates from Novo Nordisk, Genentech, Sanofi, Alnylam and more
Read More
BioCentury
|
Apr 2, 2019
Distillery Therapeutics
Ethoxyindole-based CFB inhibitor for complement-mediated diseases
Read More
BioCentury
|
Oct 12, 2018
Company News
Roche gets option to Ionis' antisense dry AMD candidate
Read More
BioCentury
|
Oct 10, 2018
Company News
Roche gets option to Ionis' antisense dry AMD candidate
Read More
BioCentury
|
Aug 18, 2017
Company News
GSK declines option to Ionis' inotersen
Read More
BioCentury
|
Aug 11, 2017
Company News
GSK declines option to Ionis' inotersen
Read More
Items per page:
10
1 - 7 of 7